liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Dietary phytoestrogens are not associated with risk of overall breast cancer but diets rich in coumestrol are inversely associated with risk of estrogen receptor and progesterone receptor negative breast tumors in Swedish women.
Karolinska Institutet.
Karolinska Institutet.
Karolinska Institutet.
University of Helsinki.
Show others and affiliations
2008 (English)In: The Journal of nutrition, ISSN 1541-6100, Vol. 138, no 5, 938-45 p.Article in journal (Refereed) Published
Abstract [en]

Results from epidemiological and experimental studies indicate that phytoestrogens may protect against breast cancer. Because one of the biological effects of phytoestrogens is probably estrogenic, it's possible that the preventive effect on breast cancer differs by estrogen receptor (ER) or progesterone receptor (PR) status of the tumor. We evaluated the associations between dietary phytoestrogen (isoflavonoids, lignans, and coumestrol) intake and risk of breast cancer and whether the ER/PR statuses of the tumor influence this relationship. In 1991-2 a prospective population-based cohort study among Swedish pre- and postmenopausal women was performed, making questionnaire data available for 45,448 women. A total of 1014 invasive breast cancers were diagnosed until December 2004. Cox proportional hazards models were performed to estimate multivariate risk ratios, 95% CI for associations with risk of breast cancer. Intakes of lignan, isoflavonoid, or coumestrol were not associated with breast cancer risk overall or before or after 50 y of age. The effects of lignans or isoflavonoids were independent of receptor status. However, intake of coumestrol was associated with decreased risk of receptor negative tumors (ER-PR-) but not positive tumors. The risk of ER-PR- tumors was significantly lower (50%) in women with intermediate coumestrol intake compared with those who did not consume any. In conclusion, we found no association between intake of isoflavonoids or lignans and breast cancer risk. Our results of a decreased risk of ER-PR- tumors in women with intermediate intake of coumestrol could be due to chance because of the low intake. The results should be confirmed in other studies.

Place, publisher, year, edition, pages
2008. Vol. 138, no 5, 938-45 p.
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-28253PubMedID: 18424605OAI: diva2:249019
Available from: 2009-10-09 Created: 2009-10-09 Last updated: 2009-10-09

Open Access in DiVA

No full text

Other links

PubMedLink to Journal

Search in DiVA

By author/editor
Löf, Marie
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 7 hits
ReferencesLink to record
Permanent link

Direct link